In addition, an oncogenic NRAS  (Q61R) gene mutation was identified in an ECD patient, further highlighting the importance of mitogen-activated protein kinase signaling to ECD pathogenesis [132]. The gene discussed is WNK2; the disease is familial atrioventricular septal defect.